Author: Victoria Stern

Authors retract, replace highly cited paper on ADHD in kids

Researchers have retracted and replaced a 2014 paper in JAMA Psychiatry, exploring a new way to classify attention deficit hyperactivity disorder (ADHD) in children, after discovering errors in the data.

Some experts have criticized the current diagnostic criteria for ADHD—noting, in some cases, it could inflate the rate of diagnosis. Sarah L. Karalunas, the paper’s corresponding author, told Retraction Watch that the aim of the study was to look beyond current criteria and “demonstrate an approach that could be used to better delineate the boundaries of ADHD and other psychiatric diagnostic categories.”   Continue reading Authors retract, replace highly cited paper on ADHD in kids

Highly cited paper by dep’t chair at Sloan Kettering is corrected — three times

A radiology journal has published an addendum to a 2005 review on cancer imaging techniques, alerting readers to figure duplication.

But that’s not what caught our attention about this case. The addendum, published in January, is the third notice that The British Journal of Radiology (BJR) has issued for the 2005 review by Hedvig Hricak, chair of the Department of Radiology at Memorial Sloan Kettering in New York City. The notices, published between 2014 and 2018, all describe duplication.

Why the series of notices, all describing a similar problem? Continue reading Highly cited paper by dep’t chair at Sloan Kettering is corrected — three times

McGill dept chair says she was blindsided by coauthor’s plagiarism

When Parisa Ariya was invited to write a review for a special issue of the journal Atmosphere, she asked one of her former doctoral students to take the lead. But she soon regretted that decision after discovering Lin (Emma) Si had plagiarized and duplicated significant portions of the review.

Ariya, chair of the Department of Atmospheric and Oceanic Sciences at McGill University in Montreal, told Retraction Watch that she believes it’s important to foster the careers of young women in science and was excited for her former student, Si, to take on the challenge of writing her first review. (Si was cc’d on our email communications with Ariya, but did not respond to our individual request for comment.)
Continue reading McGill dept chair says she was blindsided by coauthor’s plagiarism

Stem cell paper falsification leads to firing; Nobelist also penalized

Shinya Yamanaka

Kyoto University has “punitively dismissed” a researcher found guilty of falsifying nearly all of the figures in a 2017 stem cell paper.  

According to an announcement Wednesday, the university fired the paper’s corresponding author, Kohei Yamamizu, after determining he had fabricated and falsified data in all but one figure in the 2017 Stem Cell Reports paper. The findings of the investigation, which were announced in January, found that Yamamizu, who worked at the Center for iPS Cell Research and Application (CiRA), was the only person responsible for the manipulation.

But CiRA’s director, Shinya Yamanaka—who shared a Nobel Prize for his work in stem cell biology—has taken responsibility for the incident as well. In an official statement, Yamanaka said he felt “a strong responsibility for not having prevented research misconduct at our institute:”
Continue reading Stem cell paper falsification leads to firing; Nobelist also penalized

PNAS wouldn’t let authors cite unpublished manuscript. Now, it admits it was wrong.

Question: Do you value Retraction Watch? If so, would you consider a tax-deductible donation of $25, or a recurring donation of an amount of your choosing, to support us?

When researchers submitted a paper about a type of microparticle to PNAS, they wanted to give credit where it was due, and cite an unpublished manuscript that helped guide their work. But the journal’s policy forbid citing unpublished work, and the reference was removed before publication. Now, concerns from the authors of that unpublished work have prompted the journal to have a change of heart.  

Continue reading PNAS wouldn’t let authors cite unpublished manuscript. Now, it admits it was wrong.

“Absolutely mortified” after unintentionally plagiarizing, author offers to step down from new post

A few months ago, Dirk Werling discovered he had made a horrible mistake: He had inadvertently plagiarized in his recent review.

On January 20, Werling said he came across a 2016 paper while working on a grant and realized he had published some of the text in his 2018 review in Research in Veterinary Science. Werling — based at Royal Veterinary College at the University of London — told Retraction Watch:

I knew I needed to retract my paper.

Continue reading “Absolutely mortified” after unintentionally plagiarizing, author offers to step down from new post

Paper used to support WHO guidelines on preventing infections “has no scientific validity”

A surgery journal retracted a 2014 paper last month after discovering that the study has “no scientific validity.”

Mario Schietroma and his coauthors, based at the University of L’Aquila in Italy, reported that giving patients high concentrations of oxygen during and after colorectal surgery significantly reduced their risk of infections. Although the authors reported significant p-values, the retraction notice states that, “upon recalculation, no p-values were close to significant.” The University of L’Aquila told Retraction Watch it is investigating, but did not provide details. Continue reading Paper used to support WHO guidelines on preventing infections “has no scientific validity”

Authors claim clinical trial data came from one center. It came from three.

A BMJ journal has retracted a 2017 paper that made a false claim about the clinical trial in question. 

The Acupuncture in Medicine paper reported the results of a clinical trial about the impact of acupuncture and Chinese herbal medicine on stroke, gathered from one center. However, in November, the editors of the journal discovered that the authors had completed the trial at three centers, and had already published the data in Scientific Reports in 2016. The authors say the duplication and misrepresentation of the data stemmed from “confusion and misunderstanding.” Continue reading Authors claim clinical trial data came from one center. It came from three.

Author: “The retractions were about bureaucracy, not science”

A researcher has retracted two 2014 papers, after discovering they had not gone through the proper approval process before being submitted.

The papers were part of a collaboration funded by the U.S. National Institutes of Health, which focused on solving protein structures. Adam Godzik, the senior author, told Retraction Watch that all papers had to be approved by a special committee before being submitted to a journal. Given the scale of the collaboration, the committee for the Joint Center for Structural Genomics (JCSG) would assess whether researchers who had made a previous contribution to the work should be added as authors.

Proteins: Structure, Function, and Bioinformatics retracted both papers after Godzik informed the editor in August 2014 that neither article had undergone the required review before being submitted to the journal. Although Wiley agreed to the retractions in an email to Godzik in September 2014,  the papers were only pulled in January—more than three years later. Continue reading Author: “The retractions were about bureaucracy, not science”

Management researcher admits to falsification, resigns

David DeGeest

A business journal has retracted two papers after the corresponding author admitted he falsified his results.

David DeGeest, an assistant professor in the Department of Management and Marketing, has also resigned from The Hong Kong Polytechnic University, a university spokesperson told Retraction Watch.

Last month, DeGeest confessed to the Journal of Management (JOM) that he had falsified the results in two papers in the journal—one from 2015 and one from 2016.

The papers explored strategies startups can use to increase their odds of survival. The 2015 work was highlighted in the Wall Street Journal, among other outlets; one story in Business News Daily is no longer on the site.

David Allen, the editor-in-chief of the journal, told us: Continue reading Management researcher admits to falsification, resigns